Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'PharmaWatch: Biotechnology' returned 41 results - Page 1 of 3

  Sort by   
  Sorted by Rank Top-Bottom

Pharma Industry Portal  
CYGNUS Business Consulting & Research, June 2012
Pharma Industry Portal New online portal offers complete coverage of the pharma sector. Online access is provided through a User ID & Password. Additional Features - Vital Statistics on the sub


Top 10 Pharmaceutical Companies: Media Monitor  
Moreover Technologies, June 2012
BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review Checkbiotech


Top 10 Biotech Companies: Media Monitor  
Moreover Technologies, June 2012
Chemical Network CNBC CNN Community Pharmacist CompotechAsia Contract Pharma Council for Biotechnology Information Drug Discovery News Drug Discovery Online Drug Metabolism And Disposition Drug Store News


2011 Trends to Watch: Pharmaceutical Technology  
Ovum, Nov 2010, Pages: 29
patient populations will drive new drug R&D and sales growth - The high costs of developing a blockbuster drug push pharma towards alternatives - Biotechnology will fuel personalized medicine, but the dream


2010 Trends to Watch: Pharmaceutical Technology  
Datamonitor, Dec 2009, Pages: 17
business model: Pharma 2.0, new R&D models embrace biotechnology and biomedical research and the future success of pharma relies on the emerging markets. As the life sciences industry moves into its next


Stents Media Monitor  
Moreover Technologies, June 2012
Bioresearch Online Bioscience Technology Online Bioscience World/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor


Bioinformatics Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Generics, Biogenerics and Biosimilars: Media Monitor  
Moreover Technologies, June 2012
International Bioresearch Online Bioscience Technology Online Bioscience World/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo


Managed Care Media Monitoring  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Medical Imaging Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Drug Delivery Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Molecular Diagnostics Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Neuroscience Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Oncology Media Monitor  
Moreover Technologies, June 2012
BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review Checkbiotech


Orthopedics Market: Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Point of Care Diagnostics Media Monitor  
Moreover Technologies, June 2012
/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review


Vaccine Media Monitor  
Moreover Technologies, June 2012
BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal 24 Cafepharma Canada NewsWire Chain Drug Review Checkbiotech


Cardiovascular Devices: Media Monitor  
Moreover Technologies, June 2012
Bioscience Technology Online Bioscience World/Biotechnology Focus BioSpace BiotechEast Biotechnology Healthcare Bioteknologia BioTimes BioWorld BioWorld Financial Watch BörseGo Btech Investor Business Portal


Top 50 Biotechnology Companies & Their Pipelines 2010  
UBM Canon, Aug 2010, Pages: 97
Top 50 Biotechnology Companies & Their Pipelines 2010 Despite economic turmoil, biotechnology companies in the U.S., Europe, Canada, and Australia had a combined net profit of $3.7 billion in 2009, a


Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects  
PharmaVision, Aug 2010, Pages: 183
proteins and driven by advances in biotechnology, manufacturing and delivery. - mAbs have been widely used to treat cancer and immuno-inflammatory related diseases; promising new treatments are under


Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds